FREE SHIPPING ON ORDERS OVER $150

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

$22.83

Quantity
- +
Description

Pratley et al., 2019

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

Chinese Academy of Medical Sciences, p

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

Chemical modifications, such as amino acid mutations, addition of fatty acid chains, or design of synthetic analogs, can enhance their resistance to enzymatic degradation and significantly improve metabolic stability and half-life (Yu et al., 2018

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

doi: 10.1016/j.cmet.2021.01.015 139 LarsenPJTang-ChristensenMHolstJJOrskovC

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

[DOI] [PubMed] [Google Scholar] 96

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed

amylin glp 1 dual agonist GLP-1 and in the Treatment of Obesity | Current Diabetes Reports The effect of amycretin, a

You may also like

recommand products